Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia
Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Past Highlights
Results:
1 -10 of 76
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
1.
Casodex/Zoladex Biomarkers in Localised Prostate Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase IV
Biomarker/Laboratory analysis, Treatment
Completed
18 to 70
Other
D6876C00001
NCT00293696
Last Modified:
5/8/2007
 
First Published:
9/1/1994
2.
Phase III Randomized Study of Adjuvant Tamoxifen With or Without Ovarian Suppression and/or Cyclophosphamide, Methotrexate, and Fluorouracil (CMF) in Premenopausal Women With Stage I-IIIA, Unilateral, Invasive Breast Cancer (Summary Last Modified 12/2001)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Closed
70 and under
SCTN-BR9401
EU-94002, UKCCCR-ABC/BR9401, NCT00002580
Last Modified:
5/31/2007
3.
Phase III Randomized Study of Adjuvant Tamoxifen, Ovarian Suppression, and/or Chemotherapy in Women With Stage I, II, and IIIA Breast Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Closed
Not specified
NCRI-ABC
CRC-TU-BR3010, SCTN-BR9401/BR9402, YRCO-ABC, EU-94029, UKCCCR-ABC, NCT00002582
Last Modified:
9/6/2006
4.
Phase III Randomized Study of Adjuvant Tamoxifen with vs without Ovarian Ablation in Premenopausal Women with Axillary Node-Negative Receptor-Positive Breast Cancer 3 cm or Less in Diameter (Summary Last Modified 03/98)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Completed
premenopausal
NCI
E-3193
CLB-9494, NCCTG-933252, SWOG-9347, INT-0142, E3193
Last Modified:
7/20/2007
 
First Published:
11/1/1994
5.
Phase III Randomized Study of Radiotherapy With or Without Neoadjuvant Flutamide Plus Goserelin or Leuprolide in Patients With Good Prognosis, Locally Confined Adenocarcinoma of the Prostate
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Closed
Any age
NCI
RTOG-9408
NCT00002597, RTOG-94-08
Last Modified:
7/11/2008
6.
Phase III Randomized Study of Whole-Pelvic Irradiation Followed by a Cone-Down Boost to the Prostate vs Prostate Irradiation Only and of Neoadjuvant vs Adjuvant FLUT/ZDX for Adenocarcinoma of the Prostate
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Closed
any age
NCI
RTOG-9413
RTOG-94-13, NCT00769548
Last Modified:
1/4/2007
 
First Published:
3/1/1995
7.
Phase III Randomized Study of Total Androgen Blockade With or Without Pelvic Irradiation in Patients With Locally Advanced Adenocarcinoma of the Prostate
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Closed
Under 80
NCI
CAN-NCIC-PR3
CALGB-9593, ECOG-JPR03, MRC-PR07, SWOG-JPR3, EU-99013, NCI-T94-0110O, ISRCTN24991896, T94-0110, NCT00002633, PR3
Last Modified:
10/31/2008
 
First Published:
6/1/1995
8.
Phase III Randomized Study of Intermittent Versus Continuous Combined Androgen-Deprivation Therapy Comprising Bicalutamide and Goserelin in Patients With Metastatic Stage IV Prostate Cancer Responsive to Such Therapy
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Closed
Adult
NCI
SWOG-9346
SWOG-9346, CAN-NCIC-PR8, CALGB-9594, ECOG-S9346, EORTC-30985, CAN-NCIC-JPR8, INT-0162, NCT00002651, PR8
Last Modified:
10/1/1998
9.
Phase III Randomized Study of Adjuvant Cyclophosphamide/Methotrexate/Fluorouracil (CMF) vs Total Estrogen Blockade for Pre-/Perimenopausal Women with ER-Positive, Stage II Breast Cancer with 1-9 Positive Nodes (Summary Last Modified 10/98)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Closed
pre/perimenopausal 30 and over
CNR-GROCTA-010209
EU-93018
Last Modified:
5/28/2008
10.
Phase III Randomized Study of Radical Prostatectomy with vs without Neoadjuvant Hormone Therapy Using Leuprolide or Goserelin and Flutamide or Bicalutamide for Stage I/II Prostate Cancer (Summary Last Modified 08/98)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Completed
18 to 70
NCI
SWOG-S9615
SWOG-9615, S9615
Select All on One Page
1
2
3
4
Next >
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute